CLSD - Clearside Biomedical, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts8888
Avg. Estimate-0.62-0.64-2.52-2.25
Low Estimate-0.72-0.75-2.73-2.93
High Estimate-0.5-0.53-2.35-1.64
Year Ago EPS-0.72-0.65-2.33-2.52
Revenue EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts8888
Avg. EstimateN/AN/AN/A4.31M
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/A17.45M
Year Ago Sales155k55k345kN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History9/29/201712/30/20173/30/20186/29/2018
EPS Est.-0.55-0.7-0.58-0.58
EPS Actual-0.72-0.65-0.62-0.65
Difference-0.170.05-0.04-0.07
Surprise %-30.90%7.10%-6.90%-12.10%
EPS TrendCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.62-0.64-2.52-2.25
7 Days Ago-0.62-0.64-2.52-2.25
30 Days Ago-0.62-0.64-2.52-2.25
60 Days Ago-0.6-0.62-2.4-2.19
90 Days Ago-0.59-0.62-2.39-2.13
EPS RevisionsCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCLSDIndustrySectorS&P 500
Current Qtr.13.90%N/AN/A0.32
Next Qtr.1.50%N/AN/A0.43
Current Year-8.20%N/AN/A0.24
Next Year10.70%N/AN/A0.27
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A